Risk factors for preterm birth among opiate-addicted gravid women in a methadone treatment program

American Journal of Obstetrics and Gynecology

Volumn 201, Issue 3, 2009, Pages 326.e1-326.e6

  Almario, Christopher V ^a   Seligman, Neil S ^a   Dysart, Kevin C ^b   Berghella, Vincenzo ^a   Baxter, Jason K ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

drug abuse; methadone maintenance; preterm birth

Indexed keywords

ALCOHOL; AMPHETAMINE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; CANNABIS; COCAINE; DEXTROPROPOXYPHENE; METHADONE; NEUROLEPTIC AGENT; OPIATE; PHENCYCLIDINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DRUG USE; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; METHADONE TREATMENT; OPIATE ADDICTION; PREDICTOR VARIABLE; PREGNANCY; PREGNANT WOMAN; PREMATURITY; PRIORITY JOURNAL; RISK FACTOR;

EID: 69349092664     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2009.05.052     Document Type: Article

References (27)

1. Saigal S., and Doyle L.W. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 371 (2008) 261-269
2. McIntire D.D., and Leveno K.J. Neonatal mortality and morbidity rates in late preterm births compared with births at term. Obstet Gynecol 111 (2008) 35-41
3. Lindstrom K., Winbladh B., Haglund B., and Hjern A. Preterm infants as young adults: a Swedish national cohort study. Pediatrics 120 (2007) 70-77
4. Gilbert W.M., Nesbitt T.S., and Danielsen B. The cost of prematurity: quantification by gestational age and birth weight. Obstet Gynecol 102 (2003) 488-492
5. In: Behrman R.E., and Butler A.S. (Eds). Preterm birth: causes, consequences, and prevention (2007), National Academies Press, Washington, DC
6. Martin J.A., Hamilton B.E., Sutton P.D., et al. Births: final data for 2006. Natl Vital Stat Rep 57 (2009) 1-102
7. Dashe J.S., Sheffield J.S., Olscher D.A., Todd S.J., Jackson G.L., and Wendel G.D. Relationship between maternal methadone dosage and neonatal withdrawal. Obstet Gynecol 100 (2002) 1244-1249
8. Berghella V., Lim P.J., Hill M.K., Cherpes J., Chennat J., and Kaltenbach K. Maternal methadone dose and neonatal withdrawal. Am J Obstet Gynecol 189 (2003) 312-317
9. Arlettaz R., Kashiwagi M., Das-Kundu S., Fauchere J.C., Lang A., and Bucher H.U. Methadone maintenance program in pregnancy in a Swiss perinatal center (II): neonatal outcome and social resources. Acta Obstet Gynecol Scand 84 (2005) 145-150
10. Lim S., Prasad M.R., Samuels P., Gardner D.K., and Cordero L. High-dose methadone in pregnant women and its effect on duration of neonatal abstinence syndrome. Am J Obstet Gynecol 200 (2009) 70.e1-70.e5
11. Seligman N.S., Salva N., Hayes E.J., Dysart K.C., Pequignot E.C., and Baxter J.K. Predicting length of treatment for neonatal abstinence syndrome in methadone-exposed neonates. Am J Obstet Gynecol 199 (2008) 396.e1-396.e7
12. Kaltenbach K., Berghella V., and Finnegan L. Opioid dependence during pregnancy. Effects and management. Obstet Gynecol Clin North Am 25 (1998) 139-151
13. Centers for Disease Control and Prevention (CDC). HIV prevalence estimates-United States, 2006. MMWR Morb Mortal Wkly Rep 57 (2008) 1073-1076
14. Morgen C.S., Bjork C., Andersen P.K., Mortensen L.H., and Nybo Andersen A.M. Socioeconomic position and the risk of preterm birth-a study within the Danish National Birth Cohort. Int J Epidemiol 37 (2008) 1109-1120
15. Jansen P.W., Tiemeier H., Jaddoe V.W., et al. Explaining educational inequalities in preterm birth: the generation r study. Arch Dis Child Fetal Neonatal Ed 94 (2009) F28-F34
16. Vintzileos A.M., Ananth C.V., Smulian J.C., Scorza W.E., and Knuppel R.A. The impact of prenatal care in the United States on preterm births in the presence and absence of antenatal high-risk conditions. Am J Obstet Gynecol 187 (2002) 1254-1257
17. Berkley E.M., Leslie K.K., Arora S., Qualls C., and Dunkelberg J.C. Chronic hepatitis C in pregnancy. Obstet Gynecol 112 (2008) 304-310
18. Simms J., and Duff P. Viral hepatitis in pregnancy. Semin Perinatol 17 (1993) 384-393
19. Grosch-Woerner I., Puch K., Maier R.F., et al. Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV-1-infected women. HIV Med 9 (2008) 6-13
20. Cotter A.M., Garcia A.G., Duthely M.L., Luke B., and O'Sullivan M.J. Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth?. J Infect Dis 193 (2006) 1195-1201
21. Gillogley K.M., Evans A.T., Hansen R.L., Samuels S.J., and Batra K.K. The perinatal impact of cocaine, amphetamine, and opiate use detected by universal intrapartum screening. Am J Obstet Gynecol 163 (1990) 1535-1542
22. McCarthy J.J., Leamon M.H., Parr M.S., and Anania B. High-dose methadone maintenance in pregnancy: maternal and neonatal outcomes. Am J Obstet Gynecol 193 (2005) 606-610
23. Brown H.L., Britton K.A., Mahaffey D., Brizendine E., Hiett A.K., and Turnquest M.A. Methadone maintenance in pregnancy: a reappraisal. Am J Obstet Gynecol 179 (1998) 459-463
24. Shah N.R., and Bracken M.B. A systematic review and meta-analysis of prospective studies on the association between maternal cigarette smoking and preterm delivery. Am J Obstet Gynecol 182 (2000) 465-472
25. Kyrklund-Blomberg N.B., and Cnattingius S. Preterm birth and maternal smoking: risks related to gestational age and onset of delivery. Am J Obstet Gynecol 179 (1998) 1051-1055
26. Chouteau M., Namerow P.B., and Leppert P. The effect of cocaine abuse on birth weight and gestational age. Obstet Gynecol 72 (1988) 351-354
27. Phupong V., and Darojn D. Amphetamine abuse in pregnancy: the impact on obstetric outcome. Arch Gynecol Obstet 276 (2007) 167-170